TELA Bio Inc (TELA)
2.92
-0.12
(-3.95%)
USD |
NASDAQ |
Nov 15, 16:00
2.91
-0.01
(-0.34%)
Pre-Market: 20:00
TELA Bio Research and Development Expense (TTM): 9.469M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.469M |
| June 30, 2024 | 9.769M |
| March 31, 2024 | 9.96M |
| December 31, 2023 | 9.619M |
| September 30, 2023 | 9.66M |
| June 30, 2023 | 9.394M |
| March 31, 2023 | 8.982M |
| December 31, 2022 | 8.937M |
| September 30, 2022 | 7.936M |
| June 30, 2022 | 7.243M |
| March 31, 2022 | 7.071M |
| Date | Value |
|---|---|
| December 31, 2021 | 6.743M |
| September 30, 2021 | 6.181M |
| June 30, 2021 | 5.973M |
| March 31, 2021 | 5.022M |
| December 31, 2020 | 4.255M |
| September 30, 2020 | 4.013M |
| June 30, 2020 | 3.328M |
| March 31, 2020 | 3.404M |
| December 31, 2019 | 4.151M |
| September 30, 2019 | 4.207M |
| June 30, 2019 | 4.735M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
3.328M
Minimum
Jun 2020
9.96M
Maximum
Mar 2024
7.056M
Average
7.157M
Median
Research and Development Expense (TTM) Benchmarks
| Cutera Inc | 18.38M |
| IRIDEX Corp | 6.272M |
| Stereotaxis Inc | 9.182M |
| Electromed Inc | 0.656M |
| Myomo Inc | 4.090M |